TABLE 1

The characteristics of the study subjects (n = 54) at randomization

CharacteristicsPlaceboRosiglitazone
Sex (M/F)19/819/8
Age (year)63.2 ± 7.464.1 ± 7.8
Body weight (kg)89.1 ± 14.385.3 ± 17.4
BMI (kg/m2)29.6 ± 3.429.6 ± 4.7
Blood pressure (mmHg)147/78 ± 25/8141/76 ± 20/7
Fasting plasma glucose (mmol/l)7.7 ± 1.77.3 ± 2.0
A1C (%)7.1 ± 0.97.3 ± 0.9
Total cholesterol (mmol/l)4.7 ± 0.84.2 ± 0.7*
LDL cholesterol (mmol/l)2.7 ± 0.72.3 + 0.8
HDL cholesterol (mmol/l)1.2 ± 0.31.1 ± 0.2
Triglycerides (mmol/l)1.9 ± 1.01.7 ± 0.8
Medications
    β-Blockers78 (21/27)70 (19/27)
    Statins56 (15/27)44 (12/27)
    ACE inhibitors41 (11/27)44 (12/27)
    Ca blockers15 (4/27)26 (7/27)
    ASA78 (21/27)85 (23/27)
    Long-acting nitrates22 (6/27)26 (7/27)
  • Data are means ±SD or % (n).

  • *

    * P = 0.02. ASA, acetylsalicylic acid.